search
Back to results

Postoperative Return to Sexual Activity (PoRS)

Primary Purpose

Sexual Function Disturbances, Pelvic Organ Prolapse, Stress Urinary Incontinence

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Structured Counselling Tool
Sponsored by
University of Calgary
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Sexual Function Disturbances

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult women (age ≥ 18 years)
  • consented for pelvic reconstructive surgery for pelvic organ prolapse and / or urinary incontinence
  • currently sexually active as defined by self-report
  • able to speak and read English

Exclusion Criteria:

  • Not currently sexually active as defined by self-report
  • vulvar dermatologic pathology (Lichen sclerosus, lichen planus)
  • chronic pelvic pain
  • unable to consent or complete outcomes due to mental incapacity, prisoners or incarcerated women

Sites / Locations

  • Alberta Health Services, University of CalgaryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Standardized Counselling Tool

Control

Arm Description

If randomized to the treatment group, patients will be counselled using the structured counselling tool, and given a bulleted list of the counseling instrument to take home with them.

Routine postoperative counselling and care will be administered with no specific standardized counselling for return to sexual activity after surgery.

Outcomes

Primary Outcome Measures

Preparedness to return to sexual activity
Preparedness for return to sexual activity will be measured by modifying the Patient Preparedness Questionnaire, Question #11: "Overall, I feel prepared for my upcoming surgery" to make it relevant to sexual activity following surgery. We will consider women prepared if they answer "strongly agree" on a 6-point Likert scale. The scale ranges from "strongly agree" to "strongly disagree" to the modified statement: "Overall, I feel prepared for resuming sexual activity after my surgery".

Secondary Outcome Measures

Sexual Function
Sexual function will be measured by Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR) score. Higher scores indicate better sexual function. Scores can range from 0 to 125. Pain with sexual activity will be assessed by response to question 11 on PISQ-IR: "How often do you feel pain during sexual intercourse?" Possible responses to this question are: "Never", "Rarely", "Sometimes", "Usually", "Always"
Postoperative Pain
Postoperative pain will be evaluated with responses to the question: "Have you experienced pain in your pelvis in the last week (7 days)?" Responses of "yes" and "no" will be recorded
Time to Return to Sexual Function
Time to Return to Sexual Function will be determined by responses to self-report of date of return to sexual activity after surgery. The duration of time between surgery and return to sexual activity will be calculated.

Full Information

First Posted
March 30, 2022
Last Updated
May 10, 2023
Sponsor
University of Calgary
Collaborators
University of Wisconsin, Madison, Albany Medical College, Penn State University, Columbia University, University of Chicago, University of Florida, WellSpan Health, University of New Mexico, Weill Medical College of Cornell University, University of Texas at Austin
search

1. Study Identification

Unique Protocol Identification Number
NCT05342090
Brief Title
Postoperative Return to Sexual Activity
Acronym
PoRS
Official Title
Randomized Controlled Trial of Standardized Counselling on Postoperative Return to Sexual Activity After Pelvic Reconstructive Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 5, 2022 (Actual)
Primary Completion Date
October 2023 (Anticipated)
Study Completion Date
November 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Calgary
Collaborators
University of Wisconsin, Madison, Albany Medical College, Penn State University, Columbia University, University of Chicago, University of Florida, WellSpan Health, University of New Mexico, Weill Medical College of Cornell University, University of Texas at Austin

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To determine if standardized counselling regarding first sexual encounter after pelvic reconstructive surgery for pelvic organ prolapse and / or urinary incontinence improves postoperative preparedness to return to sexual activity and sexual function.
Detailed Description
The investigators will conduct a randomized controlled trial comparing standardized counselling to routine counseling regarding return to sexual activity using a previously developed structured counselling instrument. Adult women (age ≥18 years) who are undergoing reconstructive surgery for pelvic organ prolapse and / or urinary incontinence who report that they are currently sexually active (as defined by their own assessment of the meaning of this question) will be eligible to participate and recruited during their preoperative visit. The recruitment will take place across 10 sites in Canada and the Unites States. The hypothesis is that use of a newly developed standardized counselling intervention regarding resumption of sexual activity will result in improved preparedness to return to sexual function compared to routine care. The primary outcome will be preparedness at 2-6 months postoperatively. Preparedness for return to sexual activity will be measured by modifying the Patient Preparedness Questionnaire, Question #11: "Overall, I feel prepared for my upcoming surgery" to make it relevant to sexual activity following surgery. The investigators will consider women prepared if they answer "strongly agree" on a 6-point Likert scale from "strongly agree" to "strongly disagree" to the modified statement: "Overall, I feel prepared for resuming sexual activity after my surgery". In addition to the primary outcome, the investigators will compare the secondary outcomes of sexual function, time to return to sexual activity, and postoperative pain with sexual activity. Sexual function will be measured by Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR) score. Pain with sexual activity will be assessed by response to question 11 on PISQ-IR: "How often do you feel pain during sexual intercourse?" Women who have already consented for surgery for pelvic organ prolapse surgery will be approached to offer participation in the study at the pre-operative visit. After enrollment in the study, women will complete demographic information, undergo a pelvic organ prolapse quantification examination, and complete the PISQ IR and the Pelvic Floor Distress Inventory - 20 (PFDI-20). Women will then be randomized to either usual or scripted counseling for resumption of sexual activity. The randomization assignment will occur as close to the intervention as possible, i.e. the night before, or the morning of, scheduled 6-8 week postoperative appointment. The randomization schema will be generated using an online randomization table with alternating blocks of 4 and 6. If randomized to the treatment group, patients will be counselled using the structured counselling instrument, and given a bulleted list of the counseling instrument to take home with them. After the visit, women will complete the PFDI-20 and Preparedness question in telephone-administered, paper or online questionnaire format. The study team will contact each participant by telephone or electronically at 1 month intervals starting at 2 months after surgery, to ascertain whether they had returned to sexual activity. If the postoperative visit occurred at 8 weeks, the first contact will occur at 3 months. If the patient has returned to sexual activity, again defined by the patient's own interpretation of the question about return to sexual activity, then women will be asked to complete the PISQ-IR and Preparedness question by telephone-administered, mailed paper, or online questionnaire format. No further followup will be required after return to sexual activity. If women are not yet returned to sexual activity, they will be contacted at 1 month intervals, to a maximum interval of 6 months after surgery, to determine return to sexual activity and timing of administration of the PISQ-IR and Preparedness question. If a woman has not yet returned to sexual activity by 6 months, we will administer the PISQ-IR and Preparedness question by telephone-administered, mailed paper, or online questionnaire format.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sexual Function Disturbances, Pelvic Organ Prolapse, Stress Urinary Incontinence, Surgery

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
170 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standardized Counselling Tool
Arm Type
Active Comparator
Arm Description
If randomized to the treatment group, patients will be counselled using the structured counselling tool, and given a bulleted list of the counseling instrument to take home with them.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Routine postoperative counselling and care will be administered with no specific standardized counselling for return to sexual activity after surgery.
Intervention Type
Other
Intervention Name(s)
Structured Counselling Tool
Intervention Description
Participants will be administered a Structured Counselling Tool that addresses the following themes: outside influences, conflicting emotions, uncertainty, sexual changes and stability, normalization, self-image
Primary Outcome Measure Information:
Title
Preparedness to return to sexual activity
Description
Preparedness for return to sexual activity will be measured by modifying the Patient Preparedness Questionnaire, Question #11: "Overall, I feel prepared for my upcoming surgery" to make it relevant to sexual activity following surgery. We will consider women prepared if they answer "strongly agree" on a 6-point Likert scale. The scale ranges from "strongly agree" to "strongly disagree" to the modified statement: "Overall, I feel prepared for resuming sexual activity after my surgery".
Time Frame
2-6 months postoperative
Secondary Outcome Measure Information:
Title
Sexual Function
Description
Sexual function will be measured by Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR) score. Higher scores indicate better sexual function. Scores can range from 0 to 125. Pain with sexual activity will be assessed by response to question 11 on PISQ-IR: "How often do you feel pain during sexual intercourse?" Possible responses to this question are: "Never", "Rarely", "Sometimes", "Usually", "Always"
Time Frame
2-6 months postoperative
Title
Postoperative Pain
Description
Postoperative pain will be evaluated with responses to the question: "Have you experienced pain in your pelvis in the last week (7 days)?" Responses of "yes" and "no" will be recorded
Time Frame
2-6 months postoperative
Title
Time to Return to Sexual Function
Description
Time to Return to Sexual Function will be determined by responses to self-report of date of return to sexual activity after surgery. The duration of time between surgery and return to sexual activity will be calculated.
Time Frame
2-6 months postoperative

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult women (age ≥ 18 years) consented for pelvic reconstructive surgery for pelvic organ prolapse and / or urinary incontinence currently sexually active as defined by self-report able to speak and read English Exclusion Criteria: Not currently sexually active as defined by self-report vulvar dermatologic pathology (Lichen sclerosus, lichen planus) chronic pelvic pain unable to consent or complete outcomes due to mental incapacity, prisoners or incarcerated women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shunaha Kim-Fine, MD
Phone
403-944-1636
Email
shunaha.kim-fine@ahs.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Kaylee Ramage, MS
Phone
403-944-1636
Email
kaylee.ramage@ucalgary.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shunaha Kim-Fine, MD
Organizational Affiliation
University of Calgary
Official's Role
Principal Investigator
Facility Information:
Facility Name
Alberta Health Services, University of Calgary
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T3L 0C9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shunaha Kim-Fine
Phone
403-944-4419
Email
shunaha.kim-fine@ahs.ca
First Name & Middle Initial & Last Name & Degree
Shunaha Kim-Fine, MD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No identifiers will be shared among co-investigators or other researchers. This is because the information is stored in Redcap and site PIs and their research staff will only have access to IPDs in their own institution but not across outside institutions.
Citations:
PubMed Identifier
9988790
Citation
Samuelsson EC, Victor FT, Tibblin G, Svardsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):299-305. doi: 10.1016/s0002-9378(99)70203-6.
Results Reference
background
PubMed Identifier
9083302
Citation
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997 Apr;89(4):501-6. doi: 10.1016/S0029-7844(97)00058-6.
Results Reference
background
PubMed Identifier
20966694
Citation
Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010 Nov;116(5):1096-100. doi: 10.1097/AOG.0b013e3181f73729.
Results Reference
background
PubMed Identifier
31187179
Citation
Dunivan GC, McGuire BL, Rishel Brakey HA, Komesu YM, Rogers RG, Sussman AL. A longitudinal qualitative evaluation of patient perspectives of adverse events after pelvic reconstructive surgery. Int Urogynecol J. 2019 Dec;30(12):2023-2028. doi: 10.1007/s00192-019-03998-7. Epub 2019 Jun 11.
Results Reference
background
PubMed Identifier
33030874
Citation
Antosh DD, Kim-Fine S, Meriwether KV, Kanter G, Dieter AA, Mamik MM, Good M, Singh R, Alas A, Foda MA, Balk EM, Rahn DD, Rogers RG. Changes in Sexual Activity and Function After Pelvic Organ Prolapse Surgery: A Systematic Review. Obstet Gynecol. 2020 Nov;136(5):922-931. doi: 10.1097/AOG.0000000000004125.
Results Reference
background
PubMed Identifier
18060968
Citation
Kenton K, Pham T, Mueller E, Brubaker L. Patient preparedness: an important predictor of surgical outcome. Am J Obstet Gynecol. 2007 Dec;197(6):654.e1-6. doi: 10.1016/j.ajog.2007.08.059.
Results Reference
background

Learn more about this trial

Postoperative Return to Sexual Activity

We'll reach out to this number within 24 hrs